Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma

• Main Authors: Poh, H.M., Chiou, Y.S., Chong, Q.Y., Chen, R.-M., Rangappa, K.S., Ma, L., Zhu, T., Kumar, A.P., Pandey, V., Basappa, Department of Studies in Organic Chemistry, University of Mysore, Mysore, 570005, India., Lee, S.-C., Lobie, P.E.
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Published: MDPI AG 2021
• Subjects: Acquired resistance; Apoptosis; Dose-dependent toxicity; Doxorubicin; Mammary carcinoma; PI3K/AKT; Trefoil factor 3 (TFF3)
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/209544
• Institution: National University of Singapore

10.3390/cancers11101528